Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 4.08
(-1.69%)
CNY 4.08
(-1.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 103.39 Million CNY | 123.59% |
| 2022 | -438.32 Million CNY | -279.81% |
| 2021 | 243.77 Million CNY | 10.86% |
| 2020 | 219.89 Million CNY | 54.97% |
| 2019 | 141.89 Million CNY | 119.56% |
| 2018 | -725.49 Million CNY | -287.21% |
| 2017 | 387.52 Million CNY | 3.89% |
| 2016 | 373.03 Million CNY | 117.97% |
| 2015 | 171.14 Million CNY | -62.89% |
| 2014 | 461.16 Million CNY | 7.46% |
| 2013 | 429.15 Million CNY | 28.77% |
| 2012 | 333.26 Million CNY | 25.53% |
| 2011 | 265.48 Million CNY | 35.76% |
| 2010 | 195.55 Million CNY | 60.55% |
| 2009 | 121.8 Million CNY | 24.13% |
| 2008 | 98.13 Million CNY | 5.81% |
| 2007 | 92.74 Million CNY | 168.94% |
| 2006 | -134.52 Million CNY | -293.79% |
| 2005 | 69.41 Million CNY | 23.2% |
| 2004 | 56.34 Million CNY | 9.28% |
| 2003 | 51.55 Million CNY | 13.13% |
| 2002 | 45.57 Million CNY | 33.83% |
| 2001 | 34.05 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -38.03 Million CNY | 44.43% |
| 2024 Q3 | -62.65 Million CNY | -64.72% |
| 2024 Q1 | -68.45 Million CNY | -2.98% |
| 2023 Q1 | 43.99 Million CNY | 106.96% |
| 2023 Q3 | 41.96 Million CNY | -49.99% |
| 2023 Q2 | 83.9 Million CNY | 90.7% |
| 2023 FY | 103.39 Million CNY | 123.59% |
| 2023 Q4 | -66.47 Million CNY | -258.4% |
| 2022 Q4 | -632.57 Million CNY | -1014.68% |
| 2022 Q3 | 69.15 Million CNY | -9.35% |
| 2022 Q2 | 76.29 Million CNY | 50.93% |
| 2022 FY | -438.32 Million CNY | -279.81% |
| 2022 Q1 | 50.54 Million CNY | 194.75% |
| 2021 Q2 | 100.08 Million CNY | 40.98% |
| 2021 Q1 | 70.98 Million CNY | 88.23% |
| 2021 FY | 243.77 Million CNY | 10.86% |
| 2021 Q4 | -53.34 Million CNY | -142.32% |
| 2021 Q3 | 126.05 Million CNY | 25.95% |
| 2020 Q1 | 59.83 Million CNY | 506.87% |
| 2020 Q3 | 70.03 Million CNY | 14.48% |
| 2020 Q4 | 37.71 Million CNY | -46.15% |
| 2020 FY | 219.89 Million CNY | 54.97% |
| 2020 Q2 | 61.17 Million CNY | 2.23% |
| 2019 Q4 | -14.7 Million CNY | -127.04% |
| 2019 Q1 | 59.23 Million CNY | 106.43% |
| 2019 Q3 | 54.39 Million CNY | 26.55% |
| 2019 FY | 141.89 Million CNY | 119.56% |
| 2019 Q2 | 42.98 Million CNY | -27.44% |
| 2018 Q1 | 101.32 Million CNY | 42.14% |
| 2018 Q4 | -921.8 Million CNY | -3139.52% |
| 2018 Q2 | 64.66 Million CNY | -36.18% |
| 2018 Q3 | 30.32 Million CNY | -53.1% |
| 2018 FY | -725.49 Million CNY | -287.21% |
| 2017 Q4 | 71.28 Million CNY | -46.23% |
| 2017 FY | 387.52 Million CNY | 3.89% |
| 2017 Q3 | 132.58 Million CNY | 59.99% |
| 2017 Q2 | 82.86 Million CNY | -17.79% |
| 2017 Q1 | 100.8 Million CNY | 21.65% |
| 2016 Q4 | 82.86 Million CNY | -29.64% |
| 2016 FY | 373.03 Million CNY | 117.97% |
| 2016 Q1 | 82.43 Million CNY | 811.18% |
| 2016 Q3 | 117.77 Million CNY | 30.92% |
| 2016 Q2 | 89.95 Million CNY | 9.12% |
| 2015 Q1 | 57.89 Million CNY | -62.19% |
| 2015 FY | 171.14 Million CNY | -62.89% |
| 2015 Q4 | 9.04 Million CNY | -91.15% |
| 2015 Q3 | 102.19 Million CNY | 4979.06% |
| 2015 Q2 | 2.01 Million CNY | -96.52% |
| 2014 Q4 | 153.09 Million CNY | 7.77% |
| 2014 Q1 | 53.85 Million CNY | -69.29% |
| 2014 FY | 461.16 Million CNY | 7.46% |
| 2014 Q2 | 112.15 Million CNY | 108.26% |
| 2014 Q3 | 142.05 Million CNY | 26.66% |
| 2013 FY | 429.15 Million CNY | 28.77% |
| 2013 Q4 | 175.37 Million CNY | 44.37% |
| 2013 Q3 | 121.47 Million CNY | 35.25% |
| 2013 Q1 | 42.48 Million CNY | -66.49% |
| 2013 Q2 | 89.81 Million CNY | 111.43% |
| 2012 Q3 | 97.28 Million CNY | 28.16% |
| 2012 FY | 333.26 Million CNY | 25.53% |
| 2012 Q1 | 33.3 Million CNY | -63.76% |
| 2012 Q2 | 75.9 Million CNY | 127.93% |
| 2012 Q4 | 126.76 Million CNY | 30.31% |
| 2011 Q1 | 27.36 Million CNY | -51.08% |
| 2011 Q3 | 81.39 Million CNY | 25.55% |
| 2011 Q4 | 91.89 Million CNY | 12.91% |
| 2011 Q2 | 64.82 Million CNY | 136.88% |
| 2011 FY | 265.48 Million CNY | 35.76% |
| 2010 Q4 | 55.94 Million CNY | -7.22% |
| 2010 Q1 | 25.55 Million CNY | -35.93% |
| 2010 FY | 195.55 Million CNY | 60.55% |
| 2010 Q2 | 53.75 Million CNY | 110.33% |
| 2010 Q3 | 60.29 Million CNY | 12.17% |
| 2009 Q4 | 39.89 Million CNY | 25.35% |
| 2009 Q3 | 31.82 Million CNY | -10.32% |
| 2009 Q2 | 35.48 Million CNY | 142.9% |
| 2009 Q1 | 14.6 Million CNY | -48.22% |
| 2009 FY | 121.8 Million CNY | 24.13% |
| 2008 Q4 | 28.21 Million CNY | 6.02% |
| 2008 FY | 98.13 Million CNY | 5.81% |
| 2008 Q1 | 15.88 Million CNY | -33.96% |
| 2008 Q2 | 27.42 Million CNY | 72.59% |
| 2008 Q3 | 26.6 Million CNY | -2.96% |
| 2007 Q1 | 5.4 Million CNY | 103.63% |
| 2007 Q2 | 48.68 Million CNY | 800.89% |
| 2007 FY | 92.74 Million CNY | 168.94% |
| 2007 Q4 | 24.05 Million CNY | 64.78% |
| 2007 Q3 | 14.6 Million CNY | -70.01% |
| 2006 Q2 | 5.46 Million CNY | 16.72% |
| 2006 Q1 | 4.68 Million CNY | -89.29% |
| 2006 Q4 | -148.89 Million CNY | -3443.92% |
| 2006 Q3 | 4.45 Million CNY | -18.59% |
| 2006 FY | -134.52 Million CNY | -293.79% |
| 2005 Q4 | 43.75 Million CNY | 309.98% |
| 2005 FY | 69.41 Million CNY | 23.2% |
| 2005 Q1 | 4.11 Million CNY | -88.23% |
| 2005 Q2 | 10.87 Million CNY | 164.23% |
| 2005 Q3 | 10.67 Million CNY | -1.87% |
| 2004 Q1 | 4.51 Million CNY | 0.0% |
| 2004 Q3 | 7.08 Million CNY | -27.68% |
| 2004 Q2 | 9.79 Million CNY | 117.03% |
| 2004 FY | 56.34 Million CNY | 9.28% |
| 2004 Q4 | 34.96 Million CNY | 393.79% |
| 2003 FY | 51.55 Million CNY | 13.13% |
| 2002 FY | 45.57 Million CNY | 33.83% |
| 2001 FY | 34.05 Million CNY | 0.0% |